此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Effect of Xylitol Chewing Gum Consumption on Coagulation Parameters and Salivary Oral Microbiological Markers in Healthy Young Adults

2026年11月16日 更新者:Bezmialem Vakif University

The Effect of Xylitol Consumption on Blood Coagulation Parameters and Oral Microbiological Markers in Saliva in Healthy Young Adults

Xylitol is a natural sweetener that is widely used in chewing gum and oral care products because it helps prevent tooth decay. Some recent studies, mostly in older adults with heart disease or other health conditions, have raised questions about whether xylitol may affect blood clotting. It is not known whether regular, everyday amounts of xylitol have any effect on blood clotting in healthy young people.

This study will look at whether chewing xylitol gum every day for 4 weeks changes blood clotting tests in healthy adults aged 18 to 35 years. It will also look at whether xylitol gum changes the bacteria found in saliva.

Sixty healthy volunteers will be randomly assigned to one of two groups of 30 people each. One group will chew gum containing xylitol (2 pieces, 3 times a day, for a total of 6 grams of xylitol per day). The other group will chew gum that contains sorbitol instead of xylitol, in the same way and for the same length of time. Participants and researchers will know which gum is being used.

Blood and saliva samples will be collected at the start of the study and again after 4 weeks. The blood tests will measure platelet count, prothrombin time, activated partial thromboplastin time, fibrinogen, D-dimer, and thrombin-antithrombin complexes. The saliva samples will be used to study the types and amounts of bacteria in the mouth. Researchers will contact participants every week to ask how they are doing and to record any side effects.

研究概览

详细说明

Background: Xylitol is a five-carbon sugar alcohol (polyol) that occurs naturally in small amounts in fruits and vegetables. It is widely used as a low-calorie sweetener and, because it helps prevent dental caries, it is commonly added to chewing gum, lozenges and oral care products. In recent years, observational and laboratory studies of some polyol sweeteners, notably erythritol, have suggested links with increased platelet reactivity and thrombotic events. A recent publication reported that high blood levels of xylitol were associated with cardiovascular events in older adults with existing cardiovascular risk factors, and that a single high dose of xylitol (30 g in a drink) increased platelet responsiveness in healthy volunteers over a short period. These findings cannot be directly applied to healthy young adults who use xylitol regularly in everyday amounts, and the effect of repeated daily xylitol intake on blood clotting in this group has not been studied in controlled trials. Xylitol is also known to affect cariogenic bacteria in the mouth, but studies that evaluate systemic clotting markers and the oral microbial profile together are lacking.

Objectives: The primary objective is to evaluate the effect of 4 weeks of daily xylitol chewing gum use on blood coagulation and thrombotic markers in healthy young adults. The secondary objective is to evaluate changes in oral microbiological markers (oral microbiome profile and relative abundance of bacterial species) in saliva.

Study Design: This is a single-center, randomized, open-label, parallel-group, controlled trial conducted at Bezmialem Vakıf University, Faculty of Dentistry, Department of Restorative Dentistry, with blood sampling and laboratory testing performed at the Bezmialem Vakıf University Hospital. Sixty healthy volunteers aged 18 to 35 years are randomly assigned (1:1, computer-based randomization) to a xylitol group (n = 30) or a control group (n = 30). The sample size was calculated using G*Power 3.1 (effect size d = 0.8, alpha = 0.05, power = 0.80), which gave 26 participants per group; 30 per group are enrolled to allow for dropouts. Because the two gums differ in taste and appearance, blinding is not applied.

Intervention: The xylitol group chews gum containing 1 g of xylitol per piece: 2 pieces, 3 times a day, for a total of 6 g of xylitol per day for 4 weeks. The control group chews sorbitol-containing, xylitol-free gum in the same way, with the same frequency and duration. Products are supplied in single-day packs. Participants record their daily gum use in a diary, and use below 80% is defined as non-adherence. During the study, participants must avoid other sweeteners, other chewing gum, polyol-rich products, oral care products that affect the oral flora, probiotics, and nutritional supplements, as well as medicines and herbal products that affect blood clotting.

Study Procedures: At baseline (Day 0), participants receive information, give written informed consent, and are screened by medical history and the eligibility criteria. After an overnight fast of at least 8 hours, a venous blood sample is taken at the hospital laboratory. A saliva sample is collected by a non-invasive method, with participants asked not to eat, drink or chew gum for at least 30 minutes beforehand. Participants then receive their study gum and instructions. Researchers contact participants once a week (telephone, message or in person) to check adherence, concurrent medication and any side effects such as gastrointestinal complaints, allergic reactions, or bleeding- or clotting-related symptoms. At the end of Week 4, blood and saliva sampling is repeated in the same way.

Measurements: Blood: platelet count, prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, D-dimer, and thrombin-antithrombin (TAT) complexes. Saliva: oral microbiome profile and relative abundance of bacterial species. Saliva samples are coded, contain no personal identifiers, and only the microbial content is analyzed; human genome sequences are excluded from analysis.

Statistical Analysis: For each parameter, the change from baseline to Week 4 is calculated and compared between the xylitol and control groups. Normality is tested with the Shapiro-Wilk test. Independent-samples t-test (or Mann-Whitney U test) is used for between-group comparisons, and paired t-test (or Wilcoxon signed-rank test) for within-group comparisons. Repeated-measures ANOVA is used to assess time-by-group interaction where appropriate. Categorical variables are compared with chi-square or Fisher's exact test. Oral microbiome data are summarized by relative abundance and diversity indices (for example, Shannon index), and associations with coagulation markers are examined by correlation analysis. Results are reported with effect sizes and 95% confidence intervals. A two-sided p value below 0.05 is considered statistically significant.

Safety: Xylitol is a food-grade sweetener generally recognized as safe, and the 6 g daily dose is within commonly used consumption levels. Participants are healthy adults with no clotting disorders and no use of anticoagulant or antiplatelet medicines. Participants who develop a serious adverse event, a clinically significant abnormal laboratory result, or a condition requiring prohibited medication are withdrawn and referred for medical care. Participants may leave the study at any time without giving a reason. Personal data are stored under coded identifiers in accordance with Turkish personal data protection law and the Declaration of Helsinki.

研究类型

介入性

注册 (估计的)

60

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 35年 (成人)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Healthy male or female adults aged 18 to 35 years
  • Body mass index (BMI) 18.5 to 24.9 kg/m²
  • Judged healthy by medical history and clinical evaluation, with no systemic disease (cardiovascular, metabolic, endocrine, hematologic, immune, liver or kidney)
  • No regular medication use, in particular no anticoagulant, antiplatelet, corticosteroid, immunosuppressant or hormonal medicines
  • No use of antibiotics in the last 4 weeks, and no use of antiseptic mouthwash (for example chlorhexidine) in the last 2 weeks
  • Non-smoker, with no regular alcohol or substance use
  • No active oral infection, acute periodontal disease or advanced dental pathology
  • No known allergy to xylitol, sorbitol or other chewing gum ingredients
  • Agrees not to use other chewing gum, sweeteners, oral care products or probiotics during the study
  • Able to attend follow-up contacts and to follow study instructions
  • Has read and signed the written informed consent form

Exclusion Criteria:

  • Chronic systemic disease (for example diabetes, hypertension, coronary artery disease, thyroid disease, hematologic disorder, liver or kidney failure)
  • Coagulation disorder, clotting factor deficiency, or family history of thrombosis
  • Use of anticoagulants, antiplatelets, corticosteroids, immunosuppressants or hormonal medicines, including oral contraceptives
  • Known allergy, intolerance or marked gastrointestinal sensitivity to xylitol, sorbitol, other sugar alcohols or gum ingredients
  • Pregnancy, breastfeeding, or planned pregnancy
  • Systemic antibiotic use in the last 4 weeks, or regular antiseptic mouthwash use (for example chlorhexidine, povidone-iodine) in the last 2 weeks
  • Surgery, blood transfusion, serious infection or hospital stay in the last 3 months
  • Smoking, or regular alcohol or substance use
  • Active periodontal disease, oral infection, oral mucosal lesion or marked gingival bleeding
  • Professional athletes or people who exercise very intensively
  • Wish to use other sweeteners, energy drinks, vitamins or nutritional supplements during the study
  • Psychiatric illness or cognitive impairment that prevents giving informed consent
  • Regular physician supervision or chronic medication use

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:基础科学
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Xylitol gum

Participants chew xylitol chewing gum (1 g of xylitol per piece), 2 pieces 3 times a day, for a total of 6 g of xylitol per day for 4 weeks.

Chewing gum containing 1 g of xylitol per piece. Participants chew 2 pieces 3 times a day (6 g of xylitol per day) for 4 weeks.

有源比较器:Sorbitol gum

Participants chew xylitol-free, sorbitol-containing chewing gum, 2 pieces 3 times a day, with the same frequency and duration as the xylitol group, for 4 weeks.

Xylitol-free chewing gum containing sorbitol. Participants chew 2 pieces 3 times a day for 4 weeks, with the same frequency and duration as the xylitol group.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in blood coagulation parameters following xylitol consumption
大体时间:Baseline and Day 30

Changes in platelet count, prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen, D-dimer, and thrombin-antithrombin (TAT) complex levels will be evaluated

Baseline and Day 30

次要结果测量

结果测量
措施说明
大体时间
Change in relative abundance of bacterial species in saliva
大体时间:Baseline and Day 30

Change from baseline to Week 4 in the relative abundance of bacterial species in saliva samples, assessed by oral microbiome analysis

Baseline and Day 30

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年7月1日

初级完成 (估计的)

2027年2月15日

研究完成 (估计的)

2027年6月1日

研究注册日期

首次提交

2026年11月16日

首先提交符合 QC 标准的

2026年11月16日

首次发布 (实际的)

2026年11月20日

研究记录更新

最后更新发布 (实际的)

2026年11月20日

上次提交的符合 QC 标准的更新

2026年11月16日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅